WHO ICTRP trial
A New Exploration of the Time Node of Polyethylene Glycolized Recombinant Human…
ChiCTR2100051414 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2100051414 |
|---|---|
| Public title | A New Exploration of the Time Node of Polyethylene Glycolized Recombinant Human Granulocyte Colony-stimulating Factor |
| Scientific title | A New Exploration of the Time-Point of Use of Polyethylene Glycol-conjugated Recombinant Human Granulocyte Colony-Stimulating Factor after Chemotherapy for Breast Cancer, a Single-Center, Cohort, Interventional Phase IV Clinical Study |
| Primary sponsor | The Seventh Affiliated Hospital, Sun Yat-sen University (Shenzhen) |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | breast cancer |
| Interventions | Group 1:PEG-rhG-CSF was injected 4 hours after chemotherapy;Group 2:PEG-rhG-CSF was injected 48 hours after chemotherapy |
| Registration date | Sep 23, 2021 |
| Target size | Group 1:41;Group 2:42 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: